Lerman, J. B., Giamberardino, S. N., McNulty, S. E., Kraus, W. E., Holley, C. L., Hernandez, A. F., … McGarrah, R. W. (2019). A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial. In CIRCULATION RESEARCH (Vol. 125). Boston, MA: LIPPINCOTT WILLIAMS & WILKINS.

Lerman, Joseph B., Stephanie N. Giamberardino, Steven E. McNulty, William E. Kraus, Christopher L. Holley, Adrian F. Hernandez, Svati H. Shah, and Robert W. McGarrah. “A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial.” In CIRCULATION RESEARCH, Vol. 125. LIPPINCOTT WILLIAMS & WILKINS, 2019.

Lerman JB, Giamberardino SN, McNulty SE, Kraus WE, Holley CL, Hernandez AF, et al. A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial. In: CIRCULATION RESEARCH. LIPPINCOTT WILLIAMS & WILKINS; 2019.

Lerman, Joseph B., et al. “A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial.” CIRCULATION RESEARCH, vol. 125, LIPPINCOTT WILLIAMS & WILKINS, 2019.

Lerman JB, Giamberardino SN, McNulty SE, Kraus WE, Holley CL, Hernandez AF, Shah SH, McGarrah RW. A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial. CIRCULATION RESEARCH. LIPPINCOTT WILLIAMS & WILKINS; 2019.